These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7829868)

  • 1. Laboratory scale production of monoclonal antibodies in a tumbling chamber.
    Jaspert R; Geske T; Teichmann A; Kassner YM; Kretzschmar K; L'age-Stehr J
    J Immunol Methods; 1995 Jan; 178(1):77-87. PubMed ID: 7829868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale production of monoclonal antibodies in dialysis tubing.
    Sjögren-Jansson E; Jeansson S
    J Immunol Methods; 1985 Nov; 84(1-2):359-64. PubMed ID: 4067321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oscillating bubble chamber for laboratory scale production of monoclonal antibodies as an alternative to ascitic tumours.
    Pannell R; Milstein C
    J Immunol Methods; 1992 Jan; 146(1):43-8. PubMed ID: 1735780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new protein- and hormone-free medium for hybridoma cultivation.
    Toyoda K; Inouye K
    Agric Biol Chem; 1991 Jun; 55(6):1631-3. PubMed ID: 1368706
    [No Abstract]   [Full Text] [Related]  

  • 5. [Production of monoclonal antibodies in serum-free medium in dialysis tubing].
    Witt S; Ziegler B; Blumentritt C; Schlosser M; Ziegler M
    Allerg Immunol (Leipz); 1991; 37(2):67-74. PubMed ID: 1801593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cultivation of mouse-mouse hybridomas producing IgM monoclonal antibodies.
    Knezević M; Alscher M; Zunec P; Hartman-Pretnar K; Rozman P; Curin-Serbec V
    Pflugers Arch; 1996; 431(6 Suppl 2):R231-2. PubMed ID: 8739349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas.
    Thompson KM; Melamed MD; Eagle K; Gorick BD; Gibson T; Holburn AM; Hughes-Jones NC
    Immunology; 1986 May; 58(1):157-60. PubMed ID: 3011653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of human monoclonal antibodies in dialysis tubing.
    Sjögren-Jansson E; Ohlin M; Borrebaeck CA; Jeansson S
    Hybridoma; 1991 Jun; 10(3):411-9. PubMed ID: 1916852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridoma cell growth and anti-neuroblastoma monoclonal antibody production in spinner flasks using a protein-free medium with microcarriers.
    Voigt A; Zintl F
    J Biotechnol; 1999 Feb; 68(2-3):213-26. PubMed ID: 10194858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous production of large amounts of monoclonal immunoglobulins in hollow fibers using protein-free medium.
    Dhainaut F; Bihoreau N; Meterreau JL; Lirochon J; Vincentelli R; Mignot G
    Cytotechnology; 1992; 10(1):33-41. PubMed ID: 1369103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth kinetics of hybridoma cells: (1) The effects of varying foetal calf serum levels.
    Low K; Harbour C
    Dev Biol Stand; 1985; 60():17-24. PubMed ID: 4043533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling and predicting monoclonal antibody production in hollow-fiber bioreactors.
    Handa-Corrigan A; Nikolay S; Jeffery D; Heffernan B; Young A
    Enzyme Microb Technol; 1992 Jan; 14(1):58-63. PubMed ID: 1367811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple and inexpensive high density dialysis tubing cell culture system for the in vitro production of monoclonal antibodies in high concentration.
    Falkenberg FW; Hengelage T; Krane M; Bartels I; Albrecht A; Holtmeier N; Wüthrich M
    J Immunol Methods; 1993 Oct; 165(2):193-206. PubMed ID: 8228270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pristane on ascites tumor formation and monoclonal antibody production.
    Hoogenraad NJ; Wraight CJ
    Methods Enzymol; 1986; 121():375-81. PubMed ID: 3724477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology.
    Trebak M; Chong JM; Herlyn D; Speicher DW
    J Immunol Methods; 1999 Nov; 230(1-2):59-70. PubMed ID: 10594354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective generation of antigen-specific human hybridomas optimized for large scale growth in serum-free medium.
    Lang AB; Schürch U; Zimmermann F; Bruderer U
    J Immunol Methods; 1992 Sep; 154(1):21-6. PubMed ID: 1401940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-based monitoring and control of a monoclonal antibody production process.
    Biener RK; Waldraff W; Noé W; Haas J; Howaldt M; Gilles ED
    Ann N Y Acad Sci; 1996 May; 782():272-85. PubMed ID: 8659904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: effect of nutrient concentration.
    Franĕk F; Dolníková J
    Cytotechnology; 1991 Sep; 7(1):33-8. PubMed ID: 1367699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coiled tube membrane bioreactor for cultivation of hybridoma cells producing monoclonal antibodies.
    Hagedorn J; Kargi F
    Enzyme Microb Technol; 1990 Nov; 12(11):824-9. PubMed ID: 1366861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
    Takahashi M; Fuller SA; Hurrell JG
    J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.